In Silico Analysis of Potential Drug Targets for Protozoan Infections
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
BACKGROUND: Currently, protozoan infectious diseases affect billions of people every year. Their pharmacological treatments offer few alternatives and are restrictive due to undesirable side effects and parasite drug resistance.
OBJECTIVE: In this work, three ontology-based approaches were used to identify shared potential drug targets in five species of protozoa.
METHODS: In this study, proteomes of five species of protozoa: Entamoeba histolytica (E. histolytica), Giardia lamblia (G. lamblia), Trichomonas vaginalis (T. vaginalis), Trypanosoma cruzi (T. cruzi), and Leishmania mexicana (L. mexicana), were compared through orthology inference using three different tools to identify potential drug targets.
RESULTS: Comparing the proteomes of E. histolytica, G. lamblia, T. vaginalis, T. cruzi, and L. mexicana, twelve targets for developing new drugs with antiprotozoal activity were identified.
CONCLUSION: New drug targets were identified by orthology-based analysis; therefore, they could be considered for the development of new broad-spectrum antiprotozoal drugs. Particularly, triosephosphate isomerase emerges as a common target in trypanosomatids and amitochondriate parasites.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
|---|---|
| Enthalten in: |
Medicinal chemistry (Shariqah (United Arab Emirates)) - 19(2022), 1 vom: 30., Seite 91-98 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Juárez-Saldivar, Alfredo [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Amitochondriates. |
|---|
| Anmerkungen: |
Date Completed 27.01.2023 Date Revised 02.02.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.2174/1573406418666220816121912 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM34494512X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM34494512X | ||
| 003 | DE-627 | ||
| 005 | 20231226023932.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1573406418666220816121912 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1149.xml |
| 035 | |a (DE-627)NLM34494512X | ||
| 035 | |a (NLM)35975866 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Juárez-Saldivar, Alfredo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a In Silico Analysis of Potential Drug Targets for Protozoan Infections |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.01.2023 | ||
| 500 | |a Date Revised 02.02.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
| 520 | |a BACKGROUND: Currently, protozoan infectious diseases affect billions of people every year. Their pharmacological treatments offer few alternatives and are restrictive due to undesirable side effects and parasite drug resistance | ||
| 520 | |a OBJECTIVE: In this work, three ontology-based approaches were used to identify shared potential drug targets in five species of protozoa | ||
| 520 | |a METHODS: In this study, proteomes of five species of protozoa: Entamoeba histolytica (E. histolytica), Giardia lamblia (G. lamblia), Trichomonas vaginalis (T. vaginalis), Trypanosoma cruzi (T. cruzi), and Leishmania mexicana (L. mexicana), were compared through orthology inference using three different tools to identify potential drug targets | ||
| 520 | |a RESULTS: Comparing the proteomes of E. histolytica, G. lamblia, T. vaginalis, T. cruzi, and L. mexicana, twelve targets for developing new drugs with antiprotozoal activity were identified | ||
| 520 | |a CONCLUSION: New drug targets were identified by orthology-based analysis; therefore, they could be considered for the development of new broad-spectrum antiprotozoal drugs. Particularly, triosephosphate isomerase emerges as a common target in trypanosomatids and amitochondriate parasites | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Drug target | |
| 650 | 4 | |a amitochondriates. | |
| 650 | 4 | |a infectious disease | |
| 650 | 4 | |a orthology | |
| 650 | 4 | |a protozoa | |
| 650 | 4 | |a trypanosomatid | |
| 650 | 7 | |a Proteome |2 NLM | |
| 650 | 7 | |a Antiprotozoal Agents |2 NLM | |
| 700 | 1 | |a Campillo, Nuria E |e verfasserin |4 aut | |
| 700 | 1 | |a Ortiz-Perez, Eyra |e verfasserin |4 aut | |
| 700 | 1 | |a Paz-Gonzalez, Alma D |e verfasserin |4 aut | |
| 700 | 1 | |a Saavedra, Emma |e verfasserin |4 aut | |
| 700 | 1 | |a Rivera, Gildardo |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Medicinal chemistry (Shariqah (United Arab Emirates)) |d 2005 |g 19(2022), 1 vom: 30., Seite 91-98 |w (DE-627)NLM163628467 |x 1875-6638 |7 nnns |
| 773 | 1 | 8 | |g volume:19 |g year:2022 |g number:1 |g day:30 |g pages:91-98 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/1573406418666220816121912 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 19 |j 2022 |e 1 |b 30 |h 91-98 | ||